NCT04096963View on ClinicalTrials.gov

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 19, 2020

Primary Completion Date

January 24, 2022

Study Completion Date

March 28, 2023

Conditions
Non-valvular Atrial Fibrillation
Interventions
DEVICE

The WATCHMAN FLX Delivery System

WATCHMAN FLX Delivery System permit device placement in the LAA via femoral venous access and crossing the inter-atrial septum into the left atrium

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY